Intestinal microbiome disruption in patients in a long-term acute care hospital: A case for development of microbiome disruption indices to improve infection prevention

American Journal of Infection Control

Volumn 44, Issue 7, 2016, Pages 830-836

  Halpin, Alison Laufer ^a   de Man, Tom J B ^a   Kraft, Colleen S ^b   Perry, K Allison ^a   Chan, Austin W ^c   Lieu, Sung ^b   Mikell, Jeffrey ^b   Limbago, Brandi M ^a   McDonald, L Clifford ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

antibiotic use; carbapenem resistant Enterobacteriaceae; Clostridium difficile; Infection control; intestinal microbiome; long term acute care; vancomycin resistant enterococci

Indexed keywords

CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; DNA 16S; METRONIDAZOLE; PROTON PUMP INHIBITOR; QUINOLONE DERIVATIVE; VANCOMYCIN; BACTERIAL DNA; RIBOSOME DNA; RNA 16S;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CHARLSON COMORBIDITY INDEX; CLINICAL ARTICLE; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIARRHEA; DRUG EXPOSURE; ENTEROCOCCUS FAECIUM; ENVIRONMENTAL FACTOR; FECES ANALYSIS; FECES MICROFLORA; FEMALE; HUMAN; INFECTION PREVENTION; LONG TERM CARE; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROBIOLOGICAL PARAMETERS; MICROBIOME DISRUPTION INDICE; ORGAN DONOR; PEPTOCLOSTRIDIUM DIFFICILE; PILOT STUDY; VANCOMYCIN RESISTANT ENTEROCOCCUS; BACTERIUM; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; FECAL MICROBIOTA TRANSPLANTATION; FECES; GENETICS; HOSPITAL; INTESTINE FLORA; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PHYLOGENY;

ADULT; AGED; BACTERIA; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; DIARRHEA; DNA, BACTERIAL; DNA, RIBOSOMAL; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HOSPITALS; HUMANS; LONG-TERM CARE; MALE; MICROBIOTA; MIDDLE AGED; PHYLOGENY; PILOT PROJECTS; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84989892690     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2016.01.003     Document Type: Article

References (35)

1. 1 Whitman, W.B., Coleman, D.C., Wiebe, W.J., Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A 95 (1998), 6578–6583.
2. 2 Foster, J.A., Bunge, J., Gilbert, J.A., Moore, J.H., Measuring the microbiome: perspectives on advances in DNA-based techniques for exploring microbial life. Brief Bioinform 13 (2012), 420–429.
3. 3 Chow, J., Mazmanian, S.K., A pathobiont of the microbiota balances host colonization and intestinal inflammation. Cell Host Microbe 7 (2010), 265–276.
4. 4 Prescott, H.C., Dickson, R.P., Rogers, M.A., Langa, K.M., Iwashyna, T.J., Hospitalization type predicts risk of subsequent severe sepsis. Am J Respir Crit Care Med 192 (2015), 581–588.
5. 5 Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108.
6. 6 David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
7. 7 Freedberg, D.E., Salmasian, H., Friedman, C., Abrams, J.A., Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients. Am J Gastroenterol 108 (2013), 1794–1801.
8. 8 Gonzalez, A., Stombaugh, J., Lozupone, C., Turnbaugh, P.J., Gordon, J.I., Knight, R., The mind-body-microbial continuum. Dialogues Clin Neurosci 13 (2011), 55–62.
9. 9 Dethlefsen, L., Huse, S., Sogin, M.L., Relman, D.A., The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol, 6, 2008, e280.
10. 10 Taur, Y., Xavier, J.B., Lipuma, L., Ubeda, C., Goldberg, J., Gobourne, A., et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 55 (2012), 905–914.
11. 11 Donskey, C.J., Sunkesula, V.C.K., Jencson, A.L., Stone, N.D., Gould, C.V., McDonald, L.C., et al. Utility of a commercial polymerase chain reaction assay and a clinical prediction rule for detection of asymptomatic carriers of toxigenic Clostridium difficile. J Clin Microbiol 52 (2014), 315–318.
12. 12 Siegel, J.D., Rhinehart, E., Jackson, M., Chiarello, L., Management of multidrug-resistant organisms in health care settings. Am J Infect Control 35 (2006), S165–93.
13. 13 Weber, D.J., Rutala, W.A., Miller, M.B., Huslage, K., Sickbert-Bennett, E., Role of hospital surfaces in the transmission of emerging health care-associated pathogens: Norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 38:Suppl (2010), S25–33.
14. 14 Gould, C.V., Rothenberg, R., Steinberg, J.P., Antibiotic resistance in long-term acute care hospitals: the perfect storm. Infect Control Hosp Epidemiol 27 (2006), 920–925.
15. 15 Wang, X.J., Kraft, C.S., Dhere, T., Use of standard donors in fecal microbiotal transplants. South Med J 108 (2015), 68–69.
16. 16 Friedman-Moraco, R.J., Mehta, A.K., Lyon, G.M., Kraft, C.S., Fecal microbiota transplantation for refractory Clostridium difficile colitis in solid organ transplant recipients. Am J Transplant 14 (2014), 477–480.
17. 17 Stevens, V., Dumyati, G., Fine, L.S., Fisher, S.G., van Wijngaarden, E., Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 53 (2011), 42–48.
18. 18 Centers for Disease Control and Prevention, Laboratory protocol for detection of carbapenem-resistant or carbapenemase-producing, Klebsiella spp. and E. coli from rectal swabs. 2009, Centers for Disease Control and Prevention, Atlanta, GA. Available from http://www.cdc.gov/hai/pdfs/labSettings/Klebsiella_or_Ecoli.pdf Accessed February 12, 2016.
19. 19 Dave, M., Higgins, P.D., Middha, S., Rioux, K.P., The human gut microbiome: current knowledge, challenges, and future directions. Transl Res 160 (2012), 246–257.
20. 20 Edgar, R.C., Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26 (2010), 2460–2461.
21. 21 Lozupone, C., Knight, R., UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 71 (2005), 8228–8235.
22. 22 Cannon, J.P., Lee, T.A., Bolanos, J.T., Danziger, L.H., Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 24 (2005), 31–40.
23. 23 Dubberke, E.R., Reske, K.A., Yan, Y., Olsen, M.A., McDonald, L.C., Fraser, V.J., Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45 (2007), 1543–1549.
24. 24 Kager, L., Brismar, B., Malmborg, A.S., Nord, C.E., Imipenem concentrations in colorectal surgery and impact on the colonic microflora. Antimicrob Agents Chemother 33 (1989), 204–208.
25. 25 Harrison, C.J., Bratcher, D., Cephalosporins: a review. Pediatr Rev 29 (2008), 264–267 quiz 273.
26. 26 Arango, J.I., Restrepo, A., Schneider, D.L., Callander, N.S., Ochoa-Bayona, J.L., Restrepo, M.I., et al. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant 37 (2006), 517–521.
27. 27 Claesson, M.J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., de Weerd, H., Flannery, E., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 108:Suppl (2011), 4586–4591.
28. 28 Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE, 5, 2010, e10667.
29. 29 Buffie, C.G., Bucci, V., Stein, R.R., McKenney, P.T., Ling, L., Gobourne, A., et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517 (2015), 205–208.
30. 30 Ubeda, C., Bucci, V., Caballero, S., Djukovic, A., Toussaint, N.C., Equinda, M., et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun 81 (2013), 965–973.
31. 31 Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L.G., Gratadoux, J.J., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105 (2008), 16731–16736.
32. 32 Dicksved, J., Halfvarson, J., Rosenquist, M., Järnerot, G., Tysk, C., Apajalahti, J., et al. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J 2 (2008), 716–727.
33. 33 Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., et al. Human gut microbiome viewed across age and geography. Nature 486 (2012), 222–227.
34. 34 Claesson, M.J., Jeffery, I.B., Conde, S., Power, S.E., O'Connor, E.M., Cusack, S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488 (2012), 178–184.
35. 35 Tosh, P.K., McDonald, L.C., Infection control in the multidrug-resistant era: tending the human microbiome. Clin Infect Dis 54 (2012), 707–713.